GSK: towards a departure of the chair
(CercleFinance.com) - GSK (GlaxoSmithKline) announces that Sir Philip Hampton has informed its Board of Directors of his intention to leave his post as non-executive chairman, which he has held since 7 May 2015.
The board has begun to look for his successor.
"Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new Chair to oversee this process through to its conclusion over the next few years," Philip Hampton said.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The board has begun to look for his successor.
"Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new Chair to oversee this process through to its conclusion over the next few years," Philip Hampton said.
Copyright (c) 2019 CercleFinance.com. All rights reserved.